News
Viral contamination has long been a concern in biomanufacturing, especially with the increasing complexity of biologic therapies. Effective viral clearance (VC) is critical to ensure the safety of ...
Digital transformation is at the heart of many biopharmaceutical companies’ strategies for ongoing success. However, the definition of digital transformation and what it consists of differ within the ...
Even small and early-stage companies can find ways to align knowledge management practices with quality management systems (QMSs) to support consistency in decision-making and prevent need for later ...
Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...
Explore the latest news and expert commentary on Cell Culture Media, brought to you by the editors of BioProcess International ...
In this informative white paper, WuXi Biologics delves into how WuXi Biologics addressed the critical need for speed in moving biologics from DNA to Investigational New Drug (IND) application ...
This two-part review provides high-level analytical development considerations for ex vivo, genome-modified hematopoietic stem and progenitor cell (GM-HSPC) products derived from primary donor cells.
In the 24th year of this millennium, the biopharma sector navigated seismic shifts, from legislative challenges and technological advancements to restructuring and landmark acquisitions. Together, ...
Explore the latest news and expert commentary on Separation/Purification, brought to you by the editors of BioProcess International ...
Explore the latest news and expert commentary on Upstream & Downstream Processing, brought to you by the editors of BioProcess International ...
Explore the latest news and expert commentary on Pre-Clinical & Clinical Trials, brought to you by the editors of BioProcess International ...
Isolere Bio is on a mission to transform biomanufacturing and tackle the traditional limitations in downstream processing with its novel IsoTag reagents. This first-of-its-kind technology is based on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results